[ Price : $8.95]
FDA accepts for priority review an Intellia Therapeutics BLA for lonvo-z, an in vivo CRISPR-based therapy for treating hereditary ...[ Price : $8.95]
FDA acknowledges that Bristol Myers Squibbs accelerated approval of Krazati (adagrasib) in combination with cetuximab for adults w...[ Price : $8.95]
HHS names CDER acting director Michael Davis and CBER acting director Karim Mikhail as permanent directors of their respective off...[ Price : $8.95]
FDA issues a guidance entitled Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates ...[ Price : $8.95]
FDA grants Heartvue.ai a 510(k) clearance for its Heartvue.Proton, a machine learningpowered software for viewing, post-processing...[ Price : $8.95]
FDA grants AstraZenenca an accelerated approval for Etcamah (camizestrant), an estrogen receptor antagonist, in combination with a...[ Price : $8.95]
There appears to be growing opposition to FDA commissioner nominee Heidi Overton, as a letter-writing campaign is underway to bloc...[ Price : $8.95]
FDA approves Ionis Pharmaceuticals Zanvastro (zilganersen) injection for treating Alexander disease in pediatric and adult patient...